Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

10,018 total articles

Vertex EVP Sells $126K in Stock as Company Nears 52-Week High

Vertex EVP Sells $126K in Stock as Company Nears 52-Week High

Ourania Tatsis, Executive Vice President at Vertex Pharmaceuticals, sold shares under a pre-established Rule 10b5-1 trading plan, disposing of 1,887 shares across two days for roughly $915,724. The trades were filed on a Form 4 with the SEC. Vertex shares trade near their 52-week high even as the company reported a slight EPS miss for Q4 2025 and a…

Vertex Executive Sells Nearly $1.6M in Stock Across Two Days

Vertex Executive Sells Nearly $1.6M in Stock Across Two Days

Amit Sachdev, Vertex Pharmaceuticals' Executive Vice President and Chief Patient & External Affairs Officer, executed two share dispositions across February 24-25, 2026, via a company-approved 10b5-1 trading plan. The transactions reduced his directly held stake while leaving him with substantial direct and indirect holdings. The stock sales oc…

Vertex Executive Sells $2.39M in Stock as Company Nears 52-Week High

Vertex Executive Sells $2.39M in Stock as Company Nears 52-Week High

Duncan McKechnie, Vertex Pharmaceuticals' Executive Vice President and Chief Commercial Officer, sold a total of 5,783 shares across February 24-25, 2026, generating roughly $2.81 million in proceeds. The transactions were executed under a 10b5-1 plan and reported via a Form 4 filing. The trade comes while Vertex shares trade near their 52-week hig…

Engine Capital Group Buys $1.73M Stake in Orthofix (OFIX)

Engine Capital Group Buys $1.73M Stake in Orthofix (OFIX)

Engine Capital Management and related entities acquired $1.73 million of Orthofix Medical Inc. shares on February 24-25, 2026, purchasing at prices between $12.5455 and $12.9634 per share. The transactions increased the Engine-affiliated group’s direct holdings to a position that may exceed 10% of the company’s outstanding common stock. Orthofix is…

Cheesecake Factory Accounting Chief Disposes $193,688 in CAKE Shares Amid Mixed Operational Signals

Cheesecake Factory Accounting Chief Disposes $193,688 in CAKE Shares Amid Mixed Operational Signals

Ashley W. Hanscom, Principal Accounting Officer of THE CHEESECAKE FACTORY INC (NASDAQ:CAKE), sold 2,951 shares on February 25, 2026 for $193,688, according to a Form 4 filing. The transaction occurs as the stock trades near $65 with a market capitalization of $3.24 billion and a notable 30.6% year-to-date gain. The company posted modest beats on re…

Regal Rexnord CFO Disposes $503,478 in Stock Across Two Days

Regal Rexnord CFO Disposes $503,478 in Stock Across Two Days

Regal Rexnord Corp. Executive Vice President and CFO Robert Rehard sold a total of 2,257 shares of common stock on February 24 and 25, 2026, for roughly $503,478. The transactions, executed at prices between $223.00 and $223.13, occurred while the shares were trading close to a 52-week high of $229.30 after a 66% one-year advance. Post-sale, Rehard…

Addus Executive Sells $69,828 of Shares Under Pre-Established Plan

Addus Executive Sells $69,828 of Shares Under Pre-Established Plan

Monica Raines, Executive Vice President, Chief Commercial Officer and Quality Officer at Addus HomeCare Corp, disposed of 656 shares across two trades on February 24-25, 2026 under a pre-arranged 10b5-1 plan to meet tax obligations stemming from restricted stock awards. The transactions generated $69,828 in proceeds; Raines continues to directly ho…